Physician profile
Danbee A Park
NPI 1558086850
$2,635.52
in general payments reported to CMS, 2019-2025
11 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.82 · 2023: $763 · 2024: $468 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $661.62 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $657.13 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $360.86 | 2023-2025 | Camzyos, Eliquis |
| Scpharmaceuticals INC. | $237.75 | 2025 | |
| Abbott Laboratories | $187.94 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Actelion Pharmaceuticals US, INC. | $169.83 | 2025 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $125.01 | 2024 | Airsupra |
| Bridgebio Pharma, INC. | $121.36 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $79.44 | 2025 | Assure Wcd |
| Hologic Sales and Service, LLC | $19.84 | 2023 | Aptima, Thinprep 2000 Processor |
| Itamar Medical INC | $14.74 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danbee Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.